ウイルスがんの治療抵抗性獲得分子機構の解明と新規染色体外DNA標的治療の開発

• Project/Area Number: 25K00121
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 56050:Otorhinolaryngology-related
• Research Institution: Chiba University
• Principal Investigator: 中川 拓也 千葉大学, 健康疾患オミクスセンター, 特任講師 (50813531)
• Project Period (FY): 2025-02-28 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000); Fiscal Year 2027: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000); Fiscal Year 2026: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000); Fiscal Year 2025: ¥7,020,000 (Direct Cost: ¥5,400,000、Indirect Cost: ¥1,620,000)